FDA Scientific Capacity Inadequate; New Device Technology At Risk

CDRH is not equipped to understand the science behind many cutting-edge device technologies, says a Nov. 29 report from the Subcommittee on Science and Technology, an ad hoc panel of the FDA Science Board

More from Archive

More from Medtech Insight